Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1864-6433
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma ; volume:27 ; number:9 ; day:18 ; month:7 ; year:2013 ; pages:839-846 ; date:11.2013
Annals of nuclear medicine ; 27, Heft 9 (18.7.2013), 839-846, 11.2013
- Creator
-
Wakabayashi, Hiroshi
Taki, Junichi
Inaki, Anri
Nakamura, Ayane
Kayano, Daiki
Fukuoka, Makoto
Matsuo, Shinro
Nakajima, Kenichi
Kinuya, Seigo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12149-013-0755-z
- URN
-
urn:nbn:de:101:1-2021081618574139093797
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wakabayashi, Hiroshi
- Taki, Junichi
- Inaki, Anri
- Nakamura, Ayane
- Kayano, Daiki
- Fukuoka, Makoto
- Matsuo, Shinro
- Nakajima, Kenichi
- Kinuya, Seigo
- SpringerLink (Online service)
Other Objects (12)
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome
A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
Model systems in SDHx-related pheochromocytoma/paraganglioma
Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome
A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
Model systems in SDHx-related pheochromocytoma/paraganglioma
Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites
Imaging of pheochromocytoma and paraganglioma: moving beyond “lumpology” with SSTR, FDG and MIBG molecular imaging
Repeated Radionuclide therapy in metastatic paraganglioma leading to the highest reported cumulative activity of 131I-MIBG
Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
Metastatic Pheochromocytoma Diagnosed with 131I-MIBG SPECT/CT Imaging in a Patient with Pathogenic VHL Mutation
Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome
A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
Model systems in SDHx-related pheochromocytoma/paraganglioma
Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations